Serious safety events in rituximab‐treated multiple sclerosis and related disorders

Autor: Brandi L. Vollmer, Asya I. Wallach, John R. Corboy, Karolina Dubovskaya, Enrique Alvarez, Ilya Kister

Publikováno v: Annals of Clinical and Translational Neurology, Vol 7, Iss 9, Pp 1477-1487 (2020)

Abstract Introduction Studies investigating rates and risk factors for serious safety events (SSEs) during rituximab treatment of multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), and related disorders are limited. Methods Rit

Externí odkaz: https://doaj.org/article/4585ce34505c4f4cad954bab1a5911e7

Antibody response to SARS-CoV-2 vaccination following typical and three-dose dosing schedules in multiple sclerosis patients treated with disease modifying therapies

Autor: Asya I, Wallach, Matthew, Schiebel, Mary Ann, Picone

Publikováno v: Multiple Sclerosis and Related Disorders. 63:103856

Immunizations against SARS-CoV-2 virus are now available and recommended, but the effect of additional dosing of the vaccine in immunocompromised MS patients is unknown.Part I - A retrospective chart review of MS patients who were vaccinated against

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7408e6cd37df9480351a5e3208de2a75
https://doi.org/10.1016/j.msard.2022.103856

The impact of medications and medical comorbidities on sexual function in people with epilepsy

Autor: Asya I. Wallach, Christopher Elder, Jacob Pellinen, Orrin Devinsky, Peggy Guinnessey, Daniel Friedman, Derek J. Chong

Publikováno v: Epilepsy research. 172

Objective People with epilepsy experience increased rates of sexual dysfunction, often affecting quality of life. Sexual dysfunction may result from the underlying disorder, antiseizure or other medications, or comorbid psychosocial factors. This stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ce24e3a82ee8b6179dbfb18970c03dd
https://pubmed.ncbi.nlm.nih.gov/33711710

Treatment of MOG antibody associated disorders: results of an international survey

Autor: Romain Marignier, H. J. Kim, Georgina Arrambide, Brigitte Wildemann, Friedemann Paul, Tom Solomon, Kumaran Deiva, Shanthi Viswanathan, Mike Boggild, Russell C. Dale, Sudarshini Ramanathan, Saleel Chandratre, Ilya Kister, Marcelo Matiello, Gulsen Akman-Demir, Rachel Kneen, Olga Ciccarelli, Ingo Kleiter, Venkatraman Karthikeayan, Silvia Tenembaum, Peter Huppke, E Gibbons, Asya I. Wallach, Ichiro Nakashima, Kazuo Fujihara, J. Y. Hor, Marco Aurélio Lana-Peixoto, Marco Capobianco, Philippe Cabre, Maria Margherita Mancardi, Kevin Rostasy, Eric C. Klawiter, Margherita Nosadini, Mar Tintoré, Daniel Whittam, Brenda Banwell, Ayse Altintas, Jeffrey Bennett, Maria Isabel Leite, M. Apiwattankul, Anu Jacob, Brian G. Weinshenker, Wei Qiu, Simon Broadley, Zsolt Illes, Aksel Siva, Maria Pia Amato, Jacqueline Palace, J. de Seze, Douglas Kazutoshi Sato, Bernhard Hemmer, Ming K. Lim, Anne-Katrin Pröbstel, Saif Huda, Michael J. Levy, Benjamin Greenberg, Dean M. Wingerchuk, Yael Hacohen, Orhan Aktas, Lekha Pandit, Sven Jarius, Daniela Pohl, Rogier Q. Hintzen, Anthony Traboulsee

Publikováno v: J Neurol
Journal of Neurology, 267(12), 3565-3577. D. Steinkopff-Verlag
Whittam, D H, Karthikeayan, V, Gibbons, E, Kneen, R, Chandratre, S, Ciccarelli, O, Hacohen, Y, de Seze, J, Deiva, K, Hintzen, R Q, Wildemann, B, Jarius, S, Kleiter, I, Rostasy, K, Huppke, P, Hemmer, B, Paul, F, Aktas, O, Pröbstel, A K, Arrambide, G, Tintore, M, Amato, M P, Nosadini, M, Mancardi, M M, Capobianco, M, Illes, Z, Siva, A, Altintas, A, Akman-Demir, G, Pandit, L, Apiwattankul, M, Hor, J Y, Viswanathan, S, Qiu, W, Kim, H J, Nakashima, I, Fujihara, K, Ramanathan, S, Dale, R C, Boggild, M, Broadley, S, Lana-Peixoto, M A, Sato, D K, Tenembaum, S, Cabre, P, Wingerchuk, D M, Weinshenker, B G, Greenberg, B, Matiello, M, Klawiter, E C, Bennett, J L, Wallach, A I, Kister, I, Banwell, B L, Traboulsee, A, Pohl, D, Palace, J, Leite, M I, Levy, M, Marignier, R, Solomon, T, Lim, M, Huda, S & Jacob, A 2020, ' Treatment of MOG antibody associated disorders : results of an international survey ', Journal of Neurology, vol. 267, no. 12, pp. 3565–3577 . https://doi.org/10.1007/s00415-020-10026-y

Introduction: While monophasic and relapsing forms of myelin oligodendrocyte glycoprotein antibody associated disorders (MOGAD) are increasingly diagnosed world-wide, consensus on management is yet to be developed. Objective: To survey the current gl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d243c6172585dcb658a0d3ac7b1c82
http://hdl.handle.net/11577/3356339

Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline

Autor: Jayne Ness, Leslie Benson, Asya I. Wallach, Teri Schreiner, Timothy Lotze, Lauren Krupp, Emmanuelle Waubant, Michael Waltz, Moses Rodriguez, Tanuja Chitnis, Jan M. Tillema, Mark Gorman, Jennifer Graves, Leigh Charvet, Anita Belman, Manikum Moodley, Yolanda Harris, John W. Rose, Mary Rensel, Gregory Aaen, T. Charles Casper, Bianca Weinstock-Guttman, Soe Mar

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England). 26(14)

Background: Cognitive impairment occurs in approximately one-third of pediatric-onset multiple sclerosis (POMS) patients. The Symbol Digit Modalities Test (SDMT), a widely used cognitive screen in adults, has yet to be incorporated early into the sta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfccdd84fc0e4c51a9fc3f2ff3026e1
https://pubmed.ncbi.nlm.nih.gov/31775571